Embla Medical hf: Conference call details for Q2 2024
9 July 2024
Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q2 2024 Interim Report on 23 July 2024 at 7:00 CET. A conference call will be hosted on the same date at 9:00 CET / 7:00 GMT / 3:00am EST.
The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.
Slides used in the presentation will be made available on the company website at the following link: http://www.emblamedical.com/investors
The conference call webcast can be accessed through following link: Embla Medical Q2 2024 webcast
To actively participate in the Q&A session during the call please use following link for dial in options Registration form for Conference Call Q&A
Financial calendar and events 2024
23 July 2024 Q2 2024 Interim Report
Q2 virtual road show
Presentation of Q2 2024 (HC Andersen Capital)
26 Aug 2024 Økonomisk Ugebrev Life Science Conference, Copenhagen
2 Sep 2024 Road Show, Copenhagen (Danske Bank)
5 Sep 2024 Goldman Sachs Medtech and Healthcare Services Conference, London
17 Sep 2024 HC Andersen Capital Seminar, Copenhagen
19 Sep 2024 Pareto Healthcare Conference Stockholm
23 Oct 2024 Q3 2024 Interim Report
26 Nov 2024 DNB Nordic Healthcare Conference, Oslo
27 Nov 2024 Danske Bank Winter Seminar, Copenhagen
If you wish to receive Embla Medical press releases by e-mail, please register here